Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics

Repeated low-dose allergen challenge increases airway hyperresponsiveness in atopic asthmatics. However, it is not known whether low-dose allergen challenge increases airway inflammation. Eight atopic asthmatics were enrolled in a controlled, cross-over study to evaluate the effect and time course of repeated low-dose allergen challenge on airway inflammation and hyperresponsiveness. The dose of allergen to reduce forced expiratory volume in one second (FEV1) by approximately 5% was selected in a screening allergen challenge. The subjects then were challenged for five consecutive days with either diluent or the selected low-dose of allergen. Methacholine airway hyperresponsiveness (PC20,meth) was measured and sputum induced on days 1, 3 and 5 of the repeated challenge, and then 1 day and 3 days after the last challenge. Repeated low-dose allergen challenge caused small reductions in FEV1, but increased airway eosinophils and interleukin (IL)-5, airway hyperresponsiveness, asthma symptoms and beta2-agonist use, all of which peaked on days 3 or 5 of the challenge. The mean (SEM) percentage sputum eosinophils was 21.2 (0.7)% after allergen versus 3.9 (0.1)% after diluent (p<0.001); percentage EG2+ cells were 13.4 (03)% after allergen versus 1.1 (0.04)% after diluent (p<0.01) and geometric mean (GSEM) eosinophil cationic protein (ECP) was 1061.8 (1.6) microg x L(-1) after allergen versus 447.03 (1.2) microg x L(-1) after diluent (p<0.05). Geometric mean (GSEM) IL-5 was 71.4 (1.4) pg x mL(-1) after allergen versus 18.4 (1.04) pg x mL(-1) after diluent (p<0.01). All the changes had resolved by 3 days after the last challenges. The study demonstrated that repeated inhalation of a low-dose of allergen causes airway eosinophilia and increases in interleukin-5, associated with airway hyperresponsiveness, and mild worsening of asthma control, without the development of marked acute bronchoconstriction or the development of late responses.

This article has been cited by other articles:

				M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest, September 1, 2006; 130(3): 741 - 753. [Abstract] [Full Text] [PDF]

				E. Ihre, P. Gyllfors, L. E. Gustafsson, M. Kumlin, and B. Dahlen Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge Eur. Respir. J., June 1, 2006; 27(6): 1152 - 1159. [Abstract] [Full Text] [PDF]

				S J Langley, S Goldthorpe, M Craven, A Woodcock, and A Custovic Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects Thorax, January 1, 2005; 60(1): 17 - 21. [Abstract] [Full Text] [PDF]

				C. S. Murray, A. Simpson, and A. Custovic Allergens, Viruses, and Asthma Exacerbations Proceedings of the ATS, April 1, 2004; 1(2): 99 - 104. [Abstract] [Full Text] [PDF]

				B. Sitkauskiene, A.-K. Johansson, S. Sergejeva, S. Lundin, M. Sjostrand, and J. Lotvall Regulation of Bone Marrow and Airway CD34+ Eosinophils by Interleukin-5 Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 367 - 378. [Abstract] [Full Text] [PDF]

				J. de Kluijver, C. E. Evertse, J. K. Sont, J. A. Schrumpf, C. J. G. van Zeijl-van der Ham, C. R. Dick, K. F. Rabe, P. S. Hiemstra, and P. J. Sterk Are Rhinovirus-induced Airway Responses in Asthma Aggravated by Chronic Allergen Exposure? Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1174 - 1180. [Abstract] [Full Text] [PDF]

				O. Vandenplas and J-L. Malo Definitions and types of work-related asthma: a nosological approach Eur. Respir. J., April 1, 2003; 21(4): 706 - 712. [Abstract] [Full Text] [PDF]

				S. Nakae, Y. Komiyama, H. Yokoyama, A. Nambu, M. Umeda, M. Iwase, I. Homma, K. Sudo, R. Horai, M. Asano, et al. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response Int. Immunol., April 1, 2003; 15(4): 483 - 490. [Abstract] [Full Text] [PDF]

				P. M. O'Byrne and M. D. Inman Airway Hyperresponsiveness Chest, March 1, 2003; 123 (2009): 411S - 416S. [Abstract] [Full Text] [PDF]

				S A McKenzie and A Bush Difficult asthma in children Arch. Dis. Child., February 1, 2003; 88(2): 168 - 169. [Abstract] [Full Text] [PDF]

				S A McKenzie and A Bush Difficult asthma in children Thorax, October 1, 2002; 57(10): 915 - 916. [Abstract] [Full Text] [PDF]

				J. de Kluijver, C. E. Evertse, J. A. Schrumpf, H. van der Veen, A. H. Zwinderman, P. S. Hiemstra, K. F. Rabe, and P. J. Sterk Asymptomatic Worsening of Airway Inflammation during Low-Dose Allergen Exposure in Asthma: Protection by Inhaled Steroids Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 294 - 300. [Abstract] [Full Text] [PDF]

				J. L. Faul, E. A. Demers, C. M. Burke, and L. W. Poulter Alterations in Airway Inflammation and Lung Function During Corticosteroid Therapy for Atopic Asthma* Chest, May 1, 2002; 121(5): 1414 - 1420. [Abstract] [Full Text] [PDF]

				M. Palmqvist, Z-H. Cui, M. Sjostrand, A. Linden, and J. Lotvall Reduced late asthmatic response by repeated low-dose allergen exposure Eur. Respir. J., May 1, 2001; 17(5): 872 - 880. [Abstract] [Full Text] [PDF]

				A. Sydbom, A. Blomberg, S. Parnia, N. Stenfors, T. Sandstrom, and S-E. Dahlen Health effects of diesel exhaust emissions Eur. Respir. J., April 1, 2001; 17(4): 733 - 746. [Abstract] [Full Text] [PDF]

				S. Bhattacharya, B. A. Stout, M. E. Bates, P. J. Bertics, and J. S. Malter Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-5 Activate STAT5 and Induce CIS1 mRNA in Human Peripheral Blood Eosinophils Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 312 - 316. [Abstract] [Full Text] [PDF]

				C. ALMQVIST, M. WICKMAN, L. PERFETTI, N. BERGLIND, A. RENSTROM, M. HEDREN, K. LARSSON, G. HEDLIN, and P. MALMBERG Worsening of Asthma in Children Allergic to Cats, after Indirect Exposure to Cat at School Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 694 - 698. [Abstract] [Full Text] [PDF]

				G. M. GAUVREAU, G. M. RONNEN, R. M. WATSON, and P. M. O'BYRNE Exercise-induced Bronchoconstriction Does Not Cause Eosinophilic Airway Inflammation or Airway Hyperresponsiveness in Subjects with Asthma Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1302 - 1307. [Abstract] [Full Text] [PDF]

				M. Tomaki, L.-L. Zhao, J. Lundahl, M. Sjostrand, M. Jordana, A. Linden, P. O'Byrne, and J. Lotvall Eosinophilopoiesis in A Murine Model of Allergic Airway Eosinophilia: Involvement of Bone Marrow IL-5 and IL-5 Receptor {alpha} J. Immunol., October 1, 2000; 165(7): 4040 - 4050. [Abstract] [Full Text] [PDF]

				C. LEMIÈRE, A. CARTIER, J.-L. MALO, and S. B. LEHRER Persistent Specific Bronchial Reactivity to Occupational Agents in Workers with Normal Nonspecific Bronchial Reactivity Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 976 - 980. [Abstract] [Full Text]

				C. M.M. Williams and S. J. Galli Mast Cells Can Amplify Airway Reactivity and Features of Chronic Inflammation in an Asthma Model in Mice J. Exp. Med., August 7, 2000; 192(3): 455 - 462. [Abstract] [Full Text] [PDF]

				E. Rosi and G. Scano Association of sputum parameters with clinical and functional measurements in asthma Thorax, March 1, 2000; 55(3): 235 - 238. [Full Text]